Uptake of breast cancer screening in women aged over 75 years: a controversy to come?

In France, the age range for organized screening for breast cancer is 50–74 years. From a layperson’s perspective, the public health message focusing on a specific target population may be difficult to understand. The aim of this study is to assess how women aged over 75 years deal with this absence...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer prevention 2011-01, Vol.20, p.13-15
Main Authors: Eisinger, François, Viguier, Jérôme, Blay, Jean-Yves, Morère, Jean-François, Coscas, Yvan, Roussel, Claire, Pivot, Xavier
Format: Article
Language:English
Subjects:
Age Factors
Aged
Aged, 80 and over
Algorithms
Attitude to Health
Breast Neoplasms
Breast Neoplasms - diagnosis
Breast Neoplasms - economics
Cancer
Carcinoma
Carcinoma - diagnosis
Carcinoma - economics
Dissent and Disputes
Early Detection of Cancer
Early Detection of Cancer - economics
Early Detection of Cancer - psychology
Early Detection of Cancer - statistics & numerical data
Early Detection of Cancer - utilization
Female
France
France - epidemiology
Health Care Costs
Humans
Life Sciences
Mammography
Mammography - psychology
Mammography - statistics & numerical data
Mammography - utilization
Supplement article
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In France, the age range for organized screening for breast cancer is 50–74 years. From a layperson’s perspective, the public health message focusing on a specific target population may be difficult to understand. The aim of this study is to assess how women aged over 75 years deal with this absence of screening recommendations for their age group. The population-based survey, EDIFICE, was carried out by telephone in 2008. Women were interviewed with regard to their behaviour, and in particular relating to breast cancer screening. For 136 breast cancer-free women, aged 75 and above and who had undergone at least one mammography in their lifetime, the test had been done within the last 2 years for only 62 (51 %) of them. In a multiregression analysis, only one item (i.e. already having undergone at least five mammographies) was statistically associated with a higher rate of attendance (odds ratio = 3.3, 95 % confidence interval = 1.03–11.1). According to our data, for women aged 75 and above, an estimated 17 000 000 Euros are spent each year on breast cancer screening in France, the net benefit of which is still unknown.
ISSN:0959-8278
1473-5709
DOI:10.1097/01.cej.0000391564.03265.3f